Loans and Allowance for Credit Losses on Loans | Note 4: Loans and Allowance for Credit Losses on Loans Loans that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are reported at their outstanding principal balances adjusted for unearned income, charge-offs, the ACL-Loans, any unamortized deferred fees or costs on originated loans and unamortized premiums or discounts on purchased loans. For loans at amortized cost, interest income is accrued based on the unpaid principal balance. The Company has made a policy election to exclude accrued interest from the amortized cost basis of loans and reports accrued interest separately from the related loan balance in the unaudited condensed consolidated balance sheets. Accrued interest on loans totaled $60.2 million and $60.4 million at March 31, 2024 and December 31, 2023, respectively. The Company also elected not to measure an allowance for credit losses for accrued interest receivables. The accrual of interest on loans is discontinued at the time the loan is 90 days past due unless the credit is well-secured and in process of collection. Past-due status is based on contractual terms of the loan. In all cases, loans are placed on nonaccrual or charged off at an earlier date if collection of principal or interest is considered doubtful. All interest accrued but not collected for loans that are placed on nonaccrual or charged off is reversed against interest income. The interest collected on these loans is applied to the principal balance until the loan can be returned to an accrual status. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured. For all loan portfolio segments, the Company promptly charges off loans, or portions thereof, when available information confirms that specific loans are uncollectable based on information that includes, but is not limited to, (1) the deteriorating financial condition of the borrower, (2) declining collateral values, and/or (3) legal action, including bankruptcy, that impairs the borrower’s ability to adequately meet its obligations. When cash payments for accrued interest are received on nonaccrual loans in each loan class, the Company records a reduction in principal on the balance of the loan. For loan modifications, interest income is recognized on an accrual basis at the renegotiated rate if the loan is in compliance with the modified terms. The Company offers repurchase agreements to fund mortgage loans held for sale from closing until sale to an investor. Under a warehousing arrangement the Company funds a mortgage loan through secured financing. The warehousing arrangement is secured by the underlying mortgages and a combination of deposits, personal guarantees and advance rates. The Company typically holds the collateral until it is sent under a bailee arrangement instructing the investor to send proceeds to the Company. Typical investors are large financial institutions or government agencies. Interest earned from the time of funding to the time of sale is recognized as interest income as accrued. Warehouse fees are accrued as noninterest income. Loan Portfolio Summary Loans receivable at March 31, 2024 and December 31, 2023 include: March 31, December 31, 2024 2023 (In thousands) Mortgage warehouse repurchase agreements $ 1,142,994 $ 752,468 Residential real estate (1) 1,321,300 1,324,305 Multi-family financing 4,096,606 4,006,160 Healthcare financing 2,464,685 2,356,689 Commercial and commercial real estate (2)(3) 1,666,751 1,643,081 Agricultural production and real estate 65,977 103,150 Consumer and margin loans 7,912 13,700 10,766,225 10,199,553 Less: ACL-Loans 75,712 71,752 Loans Receivable $ 10,690,513 $ 10,127,801 (1) Includes $1.2 billion and $1.2 billion of All-in-One© first-lien home equity lines of credit at March 31, 2024 and December 31, 2023, respectively. (2) Includes $1.1 billion and $1.1 billion of revolving lines of credit collateralized primarily by single-family mortgage servicing rights as of March 31, 2024 and December 31, 2023, respectively. (3) Includes only $6.8 million and $8.4 million of non-owner occupied commercial real estate as of March 31, 2024 and December 31, 202 3, respectively. Risk characteristics applicable to each segment of the loan portfolio are described as follows. Mortgage Warehouse Repurchase Agreements (MTG WHRA): As a secured repurchase agreement, collateral pledged to the Company secures each individual mortgage until the mortgage company sells the loan in the secondary market. A traditional secured warehouse facility typically carries a base interest rate of the Federal Reserve’s Secured Overnight Financing Rate (“SOFR”), or mortgage note rate and a margin. Risk is evident if there is a change in the fair value of mortgage loans originated by mortgage companies in warehouse, the sale of which is the expected source of repayment under a warehouse facility. However, the warehouse customers are required to hedge the change in value of these loans to mitigate the risk, typically through forward sales contracts. Residential Real Estate Loans (RES RE): Multi-Family Financing (MF FIN): The Company specializes in originating multi-family financing that can be market rate or affordable. The portfolio includes loans for construction, acquisition, refinance, or permanent financing. Loans are typically secured by real estate mortgages, assignment of Low-Income Housing Tax Credits (“LIHTC”), and/or equity interest in the underlying properties. All loans are assessed and reviewed at a minimum based on borrower strength/experience, historical property performance, market trends, projected financial performance with regards to intended strategy, and source of repayment. Independent third-party reports are used to ensure legal conformity and support valuations of the assets. Exit strategies and sources of repayment are provided through the secondary market via governmental programs, strategic refinances, LIHTC equity installments, and cashflow from the properties. Repayment of these loans depends on the successful operation of a business or property and the borrower’s cash flows. Credit risk in these loans may be impacted by the creditworthiness of a borrower, property values and the local economy in the related market area. These loans are well-collateralized and underwritten to agency guidelines. Loans included in this segment typically carry a base rate of 30-day SOFR, that adjusts on a monthly basis, and a margin. The Company strategically focuses on loan classes that are government backed or can be sold in the secondary market. Healthcare Financing (HC FIN): The healthcare financing portfolio includes customized loan products for independent living, assisted living, memory care and skilled nursing projects. A variety of loan products are available to accommodate rehabilitation, acquisition, and refinancing of healthcare properties. Credit risk in these loans are primarily driven by local demographics and the expertise of the operators of the facilities. Repayment of these loans may include permanent loans, sales of developed property or an interim loan commitment from the Company until permanent agency-eligible financing is obtained, as well as successful operation of a business or property and the borrower’s cash flows. These loans are well-collateralized and underwritten to agency guidelines. Loans included in this segment typically carry a base rate of 30-day SOFR, that adjusts on a monthly basis, and a margin. The Company strategically focuses on loan classes that are government backed or can be sold in the secondary market. Commercial Lending and Commercial Real Estate Loans (CML & CRE): The commercial lending and commercial real estate portfolio includes loans to commercial customers for use in financing working capital needs, equipment purchases and expansions, as well as loans to commercial customers to finance land and improvements. It also includes lines of credit collateralized by servicing rights that are assessed for fair value quarterly at the Company’s request. The loans in this category are repaid primarily from the cash flow of a borrower’s principal business operation. Credit risk in these loans is driven by creditworthiness of a borrower and the economic conditions that impact the cash flow stability from business operations. Small Business Administration (“SBA”) loans are included in this category. Less than Agricultural Production and Real Estate Loans (AG & AGRE): Agricultural production loans are generally comprised of seasonal operating lines of credit to grain farmers to plant and harvest corn and soybeans and term loans to fund the purchase of equipment. The Company also offers long-term financing to purchase agricultural real estate. Specific underwriting standards have been established for agricultural-related loans including the establishment of projections for each operating year based on industry-developed estimates of farm input costs and expected commodity yields and prices. Operating lines are typically written for one year and secured by the crop and other farm assets as considered necessary. The Company is approved to sell agricultural loans in the secondary market through the Federal Agricultural Mortgage Corporation and uses this relationship to manage interest rate risk within the portfolio. Agricultural real estate loans included in this segment are typically structured with a one-year adjustable rate mortgage (“ARM”), three-year ARM or five-year ARM CMT and a margin. Agriculture production, livestock, and equipment loans are structured with variable rates that are indexed to prime or fixed for terms not exceeding five years. Consumer and Margin Loans (CON & MAR): Consumer loans are those loans secured by household assets. Margin loans are those loans secured by marketable securities. The term and maximum amount for these loans are determined by considering the purpose of the loan, the margin (advance percentage against value) in all collateral, the primary source of repayment, and the borrower’s other related cash flow. ACL-Loans The ACL-Loans is the Company’s estimate of current expected credit losses. Loans receivable is presented net of the allowance to reflect the principal balance expected to be collected over the contractual term of the loans. This life of loan allowance is established through a provision for credit losses included in net interest income as loans are recorded in the financial statements. The provision for a reporting period also reflects increases or decreases in the allowance related to changes in credit loss expectations. Actual credit losses are charged against the allowance when management believes the uncollectability of a loan balance, or a portion thereof, is confirmed. Subsequent recoveries, if any, are credited to the allowance. The ACL-Loans is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans considering relevant available information from internal and external sources, including historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral and prevailing economic conditions. The allowance also incorporates reasonable and supportable forecasts. There have been no changes to the credit quality components used to assess risk during the three months ended March 31, 2024. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as more information becomes available. The level of the ACL is believed to be adequate to absorb innate expected future losses in the loan portfolio as of the measurement date. The ACL-Loans consists of individually evaluated loans and pooled loan components. The Company’s primary portfolio segmentation is by loans with similar risk characteristics. Loans risk graded substandard and worse are individually evaluated for expected credit losses. For individually evaluated loans that are collateral dependent, the Company may use the fair value of the collateral, less estimated costs to sell, as a practical expedient as of the reporting date to determine the carrying amount of an asset and the allowance for credit losses, as applicable. A loan is considered to be collateral dependent when repayment is expected to be provided substantially through the operation or the sale of the collateral when the borrower is experiencing financial difficulty as of the reporting date. To calculate the ACL-Loans risk graded pass through special mention, the portfolio is segmented by loans with similar risk characteristics. Loan Portfolio Segment ACL-Loans Methodology Mortgage warehouse repurchase agreements Remaining Life Method Residential real estate loans Discounted Cash Flow Multi-family financing Discounted Cash Flow Healthcare financing Discounted Cash Flow Commercial and commercial real estate Discounted Cash Flow Agricultural production and real estate Remaining Life Method Consumer and margin loans Remaining Life Method Loan characteristics used in determining the segmentation included the underlying collateral, type or purpose of the loan, and expected credit loss patterns. The initial estimate of expected credit losses for each segment is based on historical credit loss experience and management’s judgement. Given the Company’s modest historical credit loss experience, peer and industry data was incorporated into the measurement. Expected life of loan credit losses are quantified using discounted cash flows and remaining life methodologies. Model results are supplemented by qualitative adjustments for risk factors relevant in assessing the expected credit losses within the portfolio segments. These adjustments may increase or decrease the estimate of expected credit losses based upon the assessed level of risk for each qualitative factor. The models utilized and the applicable qualitative adjustments require assumptions and management judgement that can be subjective in nature. The above measurement approach is also used to estimate the expected credit losses associated with unfunded loan commitments, which also incorporates expected utilization rates. The following table presents, by loan portfolio segment, the activity in the ACL-Loans for the three months ended March 31, 2024 and 2023: For the Three Months Ended March 31, 2024 MTG WHRA RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) ACL-Loans Balance, beginning of period $ 2,070 $ 7,323 $ 26,874 $ 22,454 $ 12,243 $ 619 $ 169 $ 71,752 FMBI's ACL for loans sold — (55) (186) (2) (92) (246) (12) (593) Provision for credit losses 952 (363) 1,976 2,135 763 77 (63) 5,477 Loans charged to the allowance — — — — (925) — — (925) Recoveries of loans previously charged-off — — — — 1 — — 1 Balance, end of period $ 3,022 $ 6,905 $ 28,664 $ 24,587 $ 11,990 $ 450 $ 94 $ 75,712 For the Three Months Ended March 31, 2023 MTG WHRA RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) ACL-Loans Balance, beginning of period $ 1,249 $ 7,029 $ 16,781 $ 9,882 $ 8,326 $ 565 $ 182 $ 44,014 Provision for credit losses 415 349 3,070 1,871 2,149 (22) (15) 7,817 Loans charged to the allowance — — — — — — — — Recoveries of loans previously charged-off — — — — 7 — — 7 Balance, end of period $ 1,664 $ 7,378 $ 19,851 $ 11,753 $ 10,482 $ 543 $ 167 $ 51,838 The Company recorded a total provision for credit losses of $4.7 million for the three months ended March 31, 2024. The $4.7 million total provision for credit losses consisted of $4.9 million for the ACL-Loans as shown above and $(0.2) million for the ACL-Off-Balance Sheet Credit Exposures (“OBCE’s”). The $4.9 million total provision for ACL-Loans reflected an elimination of $593,000 from the sale of FMBI branches in January 2024. The Company recorded a total provision for credit losses of $6.9 million for the three months ended March 31, 2023. The $6.9 million total provision for credit losses consisted of $7.8 million for the ACL-Loans as shown above and $(0.9) million for the ACL-OBCE’s. The following table presents, by loan portfolio segment, the activity in the ACL-Loans for the twelve months ended December 31, 2023: For the Year Ended December 31, 2023 MTG WHRA RES RE MF FIN HC FIN CML & CRE AG & AGRE CON & MAR TOTAL (In thousands) ACL-Loans Balance, beginning of period $ 1,249 $ 7,029 $ 16,781 $ 9,882 $ 8,326 $ 565 $ 182 $ 44,014 Provision for credit losses 821 328 18,493 12,572 5,232 54 (12) 37,488 Loans charged to the allowance — (34) (8,400) — (1,356) — (1) (9,791) Recoveries of loans previously charged-off — — — — 41 — — 41 Balance, end of period $ 2,070 $ 7,323 $ 26,874 $ 22,454 $ 12,243 $ 619 $ 169 $ 71,752 The below table presents the amortized cost basis and ACL-Loans allocated for collateral dependent loans, which are individually evaluated to determine expected credit losses as of March 31, 2024 and December 31, 2023: March 31, 2024 Real Estate Accounts Receivable / Equipment Other Total ACL-Loans Allocation (In thousands) RES RE $ 1,272 $ — $ — $ 1,272 $ 8 MF FIN 53,200 — — 53,200 581 HC FIN 63,283 — — 63,283 5,652 CML & CRE 168 2,628 2,657 5,453 1,780 AG & AGRE 147 — — 147 1 CON & MAR — — — — — Total collateral dependent loans $ 118,070 $ 2,628 $ 2,657 $ 123,355 $ 8,022 There were no significant changes to the types of collateral securing the Company’s collateral dependent loans compared to December 31, 2023. December 31, 2023 Real Estate Accounts Receivable / Equipment Other Total ACL-Loans Allocation (In thousands) RES RE $ 1,557 $ — $ 3 $ 1,560 $ 21 MF FIN 46,575 — — 46,575 521 HC FIN 73,909 — — 73,909 6,289 CML & CRE 146 3,603 2,684 6,433 1,132 AG & AGRE 147 — — 147 1 CON & MAR — — 3 3 — Total collateral dependent loans $ 122,334 $ 3,603 $ 2,690 $ 128,627 $ 7,964 Internal Risk Categories The Company evaluates the loan risk grading system definitions and ACL-Loans methodology on an ongoing basis. As of December 31, 2023, the Company created a newly defined special mention risk rating category to be consistent with industry practices. Loans with a Watch classification are now included in the Pass risk rating category as of December 31, 2023. This updated policy was approved by the Company’s Management Committee, to be effective as of December 31, 2023 on a prospective basis. In adherence with policy, the Company uses the following internal risk grading categories and definitions for loans since December 31, 2023: Pass Special Mention not warrant adverse classification. Loans with questions or concerns regarding collateral, adverse market conditions impacting future performance, and declining financial trends would be considered for special mention. Substandard Doubtful The following tables present the credit risk profile of the Company’s loan portfolio based on internal risk rating category as of March 31, 2024 and December 31, 2023: March 31, 2024 2024 2023 2022 2021 2020 Prior Revolving Loans TOTAL (In thousands) MTG WHRA Pass $ — $ — $ — $ — $ — $ — $ 1,142,994 $ 1,142,994 Total $ — $ — $ — $ — $ — $ — $ 1,142,994 $ 1,142,994 Charge-offs $ — $ — $ — $ — $ — $ — $ — $ — RES RE Pass $ 1,780 $ 32,353 $ 9,793 $ 6,175 $ 21,315 $ 7,400 $ 1,240,994 $ 1,319,810 Special Mention — — — — — 218 — 218 Substandard — — — — — — 1,272 1,272 Total $ 1,780 $ 32,353 $ 9,793 $ 6,175 $ 21,315 $ 7,618 $ 1,242,266 $ 1,321,300 Charge-offs $ — $ — $ — $ — $ — $ — $ — $ — MF FIN Pass $ 298,730 $ 957,019 $ 734,071 $ 114,353 $ 9,070 $ 34,587 $ 1,731,470 $ 3,879,300 Special Mention 8,000 96,900 28,559 8,400 — 1,470 20,777 164,106 Substandard — 11,667 28,360 6,534 — — 6,639 53,200 Total $ 306,730 $ 1,065,586 $ 790,990 $ 129,287 $ 9,070 $ 36,057 $ 1,758,886 $ 4,096,606 Charge-offs $ — $ — $ — $ — $ — $ — $ — $ — HC FIN Pass $ 258,604 $ 626,388 $ 936,880 $ 98,815 $ — $ 14,459 $ 398,904 $ 2,334,050 Special Mention 24,319 20,900 9,502 — — — 12,631 67,352 Substandard — 25,600 — 28,783 — — 8,900 63,283 Total $ 282,923 $ 672,888 $ 946,382 $ 127,598 $ — $ 14,459 $ 420,435 $ 2,464,685 Charge-offs $ — $ — $ — $ — $ — $ — $ — $ — CML & CRE Pass $ 4,469 $ 54,002 $ 116,479 $ 71,824 $ 19,203 $ 34,169 $ 1,360,706 $ 1,660,852 Special Mention — — — 289 157 — — 446 Substandard — — 92 776 850 60 3,675 5,453 Total $ 4,469 $ 54,002 $ 116,571 $ 72,889 $ 20,210 $ 34,229 $ 1,364,381 $ 1,666,751 Charge-offs $ — $ — $ — $ 925 $ — $ — $ — $ 925 AG & AGRE Pass $ 7,833 $ 7,875 $ 5,103 $ 2,722 $ 8,566 $ 15,515 $ 18,216 $ 65,830 Substandard — — — — — 147 — 147 Total $ 7,833 $ 7,875 $ 5,103 $ 2,722 $ 8,566 $ 15,662 $ 18,216 $ 65,977 Charge-offs $ — $ — $ — $ — $ — $ — $ — $ — CON & MAR Pass $ — $ 109 $ 28 $ 25 $ 2 $ 4,268 $ 3,480 $ 7,912 Total $ — $ 109 $ 28 $ 25 $ 2 $ 4,268 $ 3,480 $ 7,912 Charge-offs $ — $ — $ — $ — $ — $ — $ — $ — Total Pass $ 571,416 $ 1,677,746 $ 1,802,354 $ 293,914 $ 58,156 $ 110,398 $ 5,896,764 $ 10,410,748 Total Special Mention $ 32,319 $ 117,800 $ 38,061 $ 8,689 $ 157 $ 1,688 $ 33,408 $ 232,122 Total Substandard $ — $ 37,267 $ 28,452 $ 36,093 $ 850 $ 207 $ 20,486 $ 123,355 Total Doubtful $ — $ — $ — $ — $ — $ — $ — $ — Total Loans $ 603,735 $ 1,832,813 $ 1,868,867 $ 338,696 $ 59,163 $ 112,293 $ 5,950,658 $ 10,766,225 Total Charge-offs $ — $ — $ — $ 925 $ — $ — $ — $ 925 December 31, 2023 2023 2022 2021 2020 2019 Prior Revolving Loans TOTAL (In thousands) MTG WHRA Pass $ — $ — $ — $ — $ — $ — $ 752,468 $ 752,468 Total $ — $ — $ — $ — $ — $ — $ 752,468 $ 752,468 Charge-offs $ — $ — $ — $ — $ — $ — $ — $ — RES RE Pass $ 31,011 $ 10,086 $ 6,573 $ 22,725 $ 3,298 $ 9,340 $ 1,239,161 $ 1,322,194 Special Mention — — — — 59 492 — 551 Substandard — — — — — 288 1,272 1,560 Total $ 31,011 $ 10,086 $ 6,573 $ 22,725 $ 3,357 $ 10,120 $ 1,240,433 $ 1,324,305 Charge-offs $ — $ — $ — $ — $ — $ 21 $ 13 $ 34 MF FIN Pass $ 1,094,698 $ 762,448 $ 208,343 $ 77,340 $ 29,764 $ 8,455 $ 1,646,445 $ 3,827,493 Special Mention 94,973 3,189 8,400 — — 1,477 24,052 132,091 Substandard 11,682 28,360 6,534 — — — — 46,576 Total $ 1,201,353 $ 793,997 $ 223,277 $ 77,340 $ 29,764 $ 9,932 $ 1,670,497 $ 4,006,160 Charge-offs $ — $ 8,400 $ — $ — $ — $ — $ — $ 8,400 HC FIN Pass $ 752,591 $ 996,273 $ 110,197 $ — $ 14,563 $ — $ 351,110 $ 2,224,734 Special Mention 35,869 9,520 — — — — 12,658 58,047 Substandard 25,600 10,625 28,783 — — — 8,900 73,908 Total $ 814,060 $ 1,016,418 $ 138,980 $ — $ 14,563 $ — $ 372,668 $ 2,356,689 Charge-offs $ — $ — $ — $ — $ — $ — $ — $ — CML & CRE Pass $ 51,110 $ 119,386 $ 77,316 $ 21,154 $ 21,088 $ 17,066 $ 1,328,980 $ 1,636,100 Special Mention — — 292 172 — 84 — 548 Substandard — 70 1,701 878 62 — 3,672 6,383 Doubtful — — — — — 50 — 50 Total $ 51,110 $ 119,456 $ 79,309 $ 22,204 $ 21,150 $ 17,200 $ 1,332,652 $ 1,643,081 Charge-offs $ — $ 496 $ 274 $ 586 $ — $ — $ — $ 1,356 AG & AGRE Pass $ 16,850 $ 9,825 $ 6,490 $ 14,267 $ 5,237 $ 16,606 $ 33,728 $ 103,003 Special Mention — — — — — — — — Substandard — — — — — 147 — 147 Total $ 16,850 $ 9,825 $ 6,490 $ 14,267 $ 5,237 $ 16,753 $ 33,728 $ 103,150 Charge-offs $ — $ — $ — $ — $ — $ — $ — $ — CON & MAR Pass $ 748 $ 4,329 $ 247 $ 115 $ 27 $ 4,339 $ 3,862 $ 13,667 Special Mention — — — 15 15 — — 30 Substandard — — — — — 3 — 3 Total $ 748 $ 4,329 $ 247 $ 130 $ 42 $ 4,342 $ 3,862 $ 13,700 Charge-offs $ — $ — $ — $ — $ — $ 1 $ — $ 1 Total Pass $ 1,947,008 $ 1,902,347 $ 409,166 $ 135,601 $ 73,977 $ 55,806 $ 5,355,754 $ 9,879,659 Total Special Mention $ 130,842 $ 12,709 $ 8,692 $ 187 $ 74 $ 2,053 $ 36,710 $ 191,267 Total Substandard $ 37,282 $ 39,055 $ 37,018 $ 878 $ 62 $ 438 $ 13,844 $ 128,577 Total Doubtful $ — $ — $ — $ — $ — $ 50 $ — $ 50 Total Loans $ 2,115,132 $ 1,954,111 $ 454,876 $ 136,666 $ 74,113 $ 58,347 $ 5,406,308 $ 10,199,553 Total Charge-offs $ — $ 8,896 $ 274 $ 586 $ — $ 22 $ 13 $ 9,791 The Company did not have any material revolving loans converted to term loans at March 31, 2024 or December 31, 2023. Delinquent Loans The following tables present the Company’s loan portfolio aging analysis of the recorded investment in loans as of March 31, 2024 and December 31, 2023. March 31, 2024 30-59 Days 60-89 Days Greater Than Total Total Past Due Past Due 90 Days Past Due Current Loans (In thousands) MTG WHRA $ — $ — $ — $ — $ 1,142,994 $ 1,142,994 RES RE 4,588 682 218 5,488 1,315,812 1,321,300 MF FIN 24,870 — 78,910 103,780 3,992,826 4,096,606 HC FIN — 25,600 48,733 74,333 2,390,352 2,464,685 CML & CRE 1,922 — 3,006 4,928 1,661,823 1,666,751 AG & AGRE 44 10 159 213 65,764 65,977 CON & MAR — — — — 7,912 7,912 $ 31,424 $ 26,292 $ 131,026 $ 188,742 $ 10,577,483 $ 10,766,225 December 31, 2023 30-59 Days 60-89 Days Greater Than Total Total Past Due Past Due 90 Days Past Due Current Loans (In thousands) MTG WHRA $ — $ — $ — $ — $ 752,468 $ 752,468 RES RE 4,557 — 2,379 6,936 1,317,369 1,324,305 MF FIN 38,218 11,055 39,609 88,882 3,917,278 4,006,160 HC FIN — 47,275 35,999 83,274 2,273,415 2,356,689 CML & CRE 172 393 3,665 4,230 1,638,851 1,643,081 AG & AGRE 27 11 147 185 102,965 103,150 CON & MAR 1 3 18 22 13,678 13,700 $ 42,975 $ 58,737 $ 81,817 $ 183,529 $ 10,016,024 $ 10,199,553 The above tables do not include two delinquent loans that were classified as held for sale at March 31, 2024, totaling $30.2 million. Nonperforming Loans Nonaccrual loans, including modified loans to borrowers experiencing financial difficulty that have not met the six-month minimum performance criterion, are reported as nonperforming loans. For all loan classes, it is the Company’s policy to have any modified loans which are on nonaccrual status prior to being modified remain on nonaccrual status until six months of satisfactory borrower performance, at which time management would consider its return to accrual status. A loan is generally classified as nonaccrual when the Company believes that receipt of principal and interest is doubtful under the terms of the loan agreement. Most generally, this is at 90 or more days past due. The amount of interest income recognized on nonaccrual financial assets during the three months ended as of March 31, 2024 and 2023, respectively, was immaterial. The following table presents the Company’s nonaccrual loans and loans past due 90 days or more and still accruing at March 31, 2024 and December 31, 2023. March 31, December 31, 2024 2023 Total Loans > Total Loans > 90 Days & 90 Days & Nonaccrual Accruing Nonaccrual Accruing (In thousands) RES RE $ 760 $ 218 $ 1,486 $ 894 MF FIN 46,248 32,662 39,608 — HC FIN 28,783 19,950 28,783 7,216 CML & CRE 2,866 140 3,820 43 AG & AGRE 147 12 147 — CON & MAR — — 3 15 $ 78,804 $ 52,982 $ 73,847 $ 8,168 The Company did not have any nonperforming loans without an estimated ACL at March 31, 2024. Modifications to Borrowers Experiencing Financial Difficulty There were no new loans modified for borrowers experiencing financial difficulty during the three months ended March 31, 2024. The Company closely monitors the performance of loans that are modified to borrowers experiencing financial difficulty to understand the effectiveness of its modification efforts. The Company did not have loans modified in the last twelve months that were delinquent as of March 31, 2024. Foreclosures There were no residential loans in the process of foreclosure as of March 31, 2024 and December 31, 2023. Loans Purchased The Company purchased $27.7 million and $98.8 million of loans during the three months ended March 31, 2024 and 2023, respectively. |